Ratings Sasol Limited Nyse

Equities

SSL

US8038663006

Market Closed - Nyse 04:00:02 2024-07-17 pm EDT 5-day change 1st Jan Change
7.37 USD -1.47% Intraday chart for Sasol Limited -3.28% -25.86%

Summary

  • The company presents an interesting fundamental situation from a short-term investment perspective.

Strengths

  • The company's profit outlook over the next few years is a strong asset.
  • Its low valuation, with P/E ratio at 3.29 and 2.68 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
  • The stock, which is currently worth 2024 to 0.62 times its sales, is clearly overvalued in comparison with peers.
  • The company's share price in relation to its net book value makes it look relatively cheap.
  • The company has a low valuation given the cash flows generated by its activity.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

Weaknesses

  • As estimated by analysts, this group is among those businesses with the lowest growth prospects.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.

Ratings chart - Surperformance

Sector: Diversified Chemicals

1st Jan change Capi. Investor Rating ESG Refinitiv
-25.86% 4.68B -
+13.28% 86.75B
B
+6.50% 34.26B
C
+17.03% 19.32B
B
+11.81% 11.81B
A-
-22.16% 10.23B
B
-10.27% 9.73B -
+2.55% 9.45B
A-
-3.84% 8.49B
C-
+6.82% 8.36B
B
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes